Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
51%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
37%
ALSO IN PPH
PPH
27
HOLDINGS
42%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.0% | 23.8% | 17.0% |
 |
NOVARTIS AG-ADR | 6.4% | 9.1% | 6.4% |
|
JOHNSON & JOHNSON | 4.9% | 4.6% | 4.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 4.4% | 4.4% |
MEDX Overweight Relative to PPH
|
ALNYLAM PHARMACEUTICALS INC | 5.7% |
|
IONIS PHARMACEUTICALS, INC. | 5.1% |
|
ABBVIE INC | 4.4% |
|
AMGEN INC | 3.9% |
 |
ALKERMES PLC | 3.4% |
|
CRISPR THERAPEUTICS AG | 3.0% |
|
BIOGEN IDEC INC | 2.8% |
|
REGENERON PHARMACEUTICALS | 2.6% |
|
GALECTIN THERAPEUTICS INC | 1.5% |
|
BEAM THERAPEUTICS, INC. | 1.3% |
MEDX Underweight Relative to PPH
|
ELI LILLY & CO | -6.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | -6.0% |
|
MERCK & CO. INC. | -4.6% |
|
MCKESSON CORP | -4.6% |
 |
SANOFI-AVENTIS-ADR | -4.2% |
|
CENCORA INC | -3.6% |
|
ZOETIS INC | -3.2% |
|
NOVARTIS AG-ADR | -2.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.3% |
 |
TEVA PHARMACEUTICAL-SP ADR | -2.3% |